B-type natriuretic peptide as a marker of allograft rejection after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 9, 2005, Pages 1444.e5-1444.e8

  Hammerer Lercher, Angelika ^a,b   Mair, Johannes ^a   Antretter, Herwig ^a   Ruttmann, Elfriede ^a   Poelzl, Gerhard ^a   Laufer, Günther ^a   Puschendorf, Bernd ^a   Hangler, Herbert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

EID: 24344438881     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.08.018     Document Type: Article

References (20)

1. G.L. Winters, B.M. McManus Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists J Heart Lung Transplant 15 1996 728 735
2. A. Hammerer-Lercher, E. Neubauer, S. Müller, O. Pachinger, B. Puschendorf, J. Mair Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction Clin Chim Acta 310 2001 193 197
3. T.A. McDonagh, S.D. Robb, D.R. Murdoch Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9 13
4. N. Nagaya, Y. Goto, T. Nishikimi Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction Clin Sci (Lond) 96 1999 129 136
5. A.M. Richards, M.G. Nicholls, T.G. Yandle Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction Circulation 97 1998 1921 1929
6. M.G. Buckley, D. Sethi, N.D. Markandu, G.A. Sagnella, D.R. Singer, G.A. MacGregor Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure Clin Sci (Lond) 83 1992 437 444
7. A. Ationu, M. Burch, D. Singer, P. Littleton, N. Carter Cardiac transplantation affects ventricular expression of brain natriuretic peptide Cardiovasc Res 27 1993 188 191
8. A. El Gamel, N.A. Yonan, B. Keevil Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation Ann Thorac Surg 63 1997 1095 1100
9. M.G. Buckley, M.H. Yacoub, D.R. Singer Investigation of the plasma concentrations and circulating forms of BNP and ANP in orthotopic cardiac transplant recipients J Hum Hypertens 12 1998 825 826
10. B. Geny, H. Hardy, J. Lonsdorfer, B. Eisenmann, P. Haberey, F. Piquard Enhanced natriuretic response to neutral endopeptidase inhibition in heart-transplant recipients Hypertension 33 1999 969 974
11. M.E. Billingham Endomyocardial biopsy detection of acute rejection in cardiac allograft recipients Heart Vessels 1 Suppl 1985 86 90
12. S.D. Ry, A. Clerico, D. Giannessi Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method Scand J Clin Lab Invest 60 2000 81 90
13. M.H. Zweig, G. Campbell Receiver-operating characteristic (ROC) plots a fundamental evaluation tool in clinical medicine Clin Chem 39 1993 561 577
14. R.G. Masters, R.A. Davies, J.P. Veinot, P.J. Hendry, S.J. Smith, A.J. de Bold Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans Circulation 100 1999 287 291
15. M.H. Park, R.L. Scott, P.A. Uber, M.R. Mehra Bedside B-type natriuretic peptide and acute non-cellular cardiac allograft rejection J Heart Lung Transplant 21 2002 613 614
16. M.H. Park, R.L. Scott, P.A. Uber, B.C. Harris, R. Chambers, M.R. Mehra Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function Am J Cardiol 90 2002 1326 1329
17. I. Hervás, L. Almenar, J.L. Perez-Pastor Radioimmunometric assay of B-type natriuretic peptide (BNP) in heart transplantation correlation between BNP determinations and biopsy grading of rejection Nucl Med Commun 24 2003 925 931
18. L. Almenar, I. Hervás, L. Martinez-Dolz The value of brain natriuretic peptide for the diagnosis of heart transplant rejection Transplant Proc 34 2002 174 175
19. I. Claudius, Y.T. Lan, R.K. Chang, G.T. Wetzel, J. Alejos Usefulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients Am J Cardiol 92 2003 1368 1370
20. A.H. Wu, A. Smith, S. Wieczorek Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure Am J Cardiol 92 2003 628 631